The latest closing stock price for Theravance Biopharma as of November 08, 2024 is 8.94.
An investor who bought $1,000 worth of Theravance Biopharma stock at the IPO in 2014 would have $-611 today, roughly -1 times their original investment - a -9.00% compound annual growth rate over 10 years.
The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
The Theravance Biopharma 52-week high stock price is 11.71, which is 31% above the current share price.
The Theravance Biopharma 52-week low stock price is 7.44, which is 16.8% below the current share price.
The average Theravance Biopharma stock price for the last 52 weeks is 9.15.
An investor who bought $1,000 worth of Theravance Biopharma stock at the IPO in 2014 would have $-611 today, roughly -1 times their original investment - a -9.00% compound annual growth rate over 10 years.
The all-time high Theravance Biopharma stock closing price was 42.56 on June 22, 2017.
The Theravance Biopharma 52-week high stock price is 11.71, which is 31% above the current share price.
The Theravance Biopharma 52-week low stock price is 7.44, which is 16.8% below the current share price.
The average Theravance Biopharma stock price for the last 52 weeks is 9.15.